Mission

IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions.

In the News

Accepted poster presentation at the Society of Investigative Dermatology: “Identifying a core domain set to assess psoriasis in clinical trials: Delphi survey of patients and healthcare professionals from the International Dermatology Outcome Measures Psoriasis Initiative”.

Welcome to the International Dermatology Outcome Measures

International Dermatology Outcome Measures is a non-profit organization seeking to develop and validate measures throughout dermatology with an initial focus on psoriatic disease. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Launched in 2013, IDEOM seeks to bring together physicians, researchers, government agencies, pharmaceutical companies, payers and patients from around the globe to develop and validate measures throughout the field of dermatology with an initial focus on psoriasis.

The group’s inaugural meeting in Boston established a need for consistent core measurements when evaluating clinical trials and therapeutic effectiveness. At the second meeting in Toronto, the group began discussing what elements are critical to be measured in psoriatic clinical trials and in clinical practice. The third meeting focused on what patients and European regulators were interested in seeing in measures.


2018 IDEOM Call for Abstracts 

Washington, DC  - May 4-5, 2018 

Eligibility: Stakeholders, trainees, and Industry representatives at any level are eligible to submit an abstract
Submission deadline: April 12, 2018
Submission: Submit abstract by email to amanda@dermoutcomes.org along with attached application form.

DOWNLOAD NOW.


A Note from our President:

"The true finish line is when the patient gets to the right doctor and the right treatment and their disease has minimal to no impact on their quality of life."
-Alice Gottlieb, MD, PhD

IDEOM activities presented at 2018 AAD Meeting:

F083: Red Flags and Emergencies in Dermatology. The Use of Biologic Agents and Chemotherapy in Generalized Pustular
and Erythrodermic Psoriasis 

Saturday, February 17, 2018
Room 6D 

IDEOM activities will be presented at GRAPPA
Sunday, February 18, 2018    12:15 pm to 1:00 pm
Marriott Marquis Grand Ballroom 2

IGA x BSA as a Practical Approach to Assessing Psoriasis  at the poster session
Saturday, February 17, 2018    1:55 pm to 2 pm

IDEOM's Work and Opportunities for Collaboration at the NAAF Meeting 
Saturday, February  17,2018    1:15-1:45 
Rancho Santa Fe Room
 

PSA: New and Emerging Treatments will be presented at
S041: Translating Evidence into Practice:  Psoriasis Guidelines

Sunday, February 18, 2018     2:10 pm 
Ballroom 20A

F145: -Research gaps in psoriasis:  opportunities for future studies and development of new outcome measures for clinical trials 
Monday, February 19, 2018    3:30 to 5:30 pm 
Room 28A


Donate

IDEOM is a 501(C)3 organization. Should you wish to contribute to our work, please email amanda@dermoutcomes.org for more information.

IDEOM Office

1630 S. Delaware Street, Suite #5564, San Mateo, CA 94402 USA
Tel. +1-650-288-5339        
E-mail: amanda@dermoutcomes.org

              

IDEOM   |   1630 S. Delaware Street, Suite #5564   |   San Mateo, CA 94402

Powered by Wild Apricot Membership Software